World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies in the World as of Jul. 01, 2024

Rank Company Market Cap (USD) Country Sector Industry
721 Acorda Therapeutics, Inc. $18.0 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
722 Cara Therapeutics, Inc. $17.7 M United States US Healthcare US Biotechnology
723 GlycoMimetics, Inc. $17.1 M United States US Healthcare US Biotechnology
724 Lyra Therapeutics, Inc. $16.6 M United States US Healthcare US Biotechnology
725 Acer Therapeutics Inc. $16.1 M

(Nov. 1, 2023)

 United States US Healthcare US Biotechnology
726 Akari Therapeutics, Plc $16.1 M

(Jan. 1, 2024)

 United Kingdom UK Healthcare UK Biotechnology
727 Onconova Therapeutics, Inc. $15.6 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
728 BioCardia, Inc. $15.3 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
729 Aytu BioScience, Inc. $15.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
730 Frequency Therapeutics, Inc. $14.3 M

(July 1, 2023)

 United States US Healthcare US Biotechnology
731 Aileron Therapeutics, Inc. $14.3 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
732 Celyad Oncology SA $14.2 M

(July 1, 2023)

 Belgium Belgian Healthcare Belgian Biotechnology
733 Edesa Biotech, Inc. $14.1 M

(Jan. 1, 2024)

 Canada Canadian Healthcare Canadian Biotechnology
734 Orgenesis Inc. $13.9 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
735 Landos Biopharma, Inc. $13.7 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
736 PolyPid Ltd. $12.8 M

(Jan. 1, 2024)

 Israel Israeli Healthcare Israeli Biotechnology
737 Synairgen plc $12.7 M United Kingdom UK Healthcare UK Biotechnology
738 Applied Molecular Transport Inc. $11.0 M

(Dec. 1, 2023)

 United States US Healthcare US Biotechnology
739 ImmuPharma plc $10.9 M United Kingdom UK Healthcare UK Biotechnology
740 ABVC BioPharma, Inc. $10.6 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
741 Virios Therapeutics, LLC $10.4 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
742 Destiny Pharma plc $10.3 M United Kingdom UK Healthcare UK Biotechnology
743 Oncimmune Holdings plc $10.2 M United Kingdom UK Healthcare UK Biotechnology
744 Cyclerion Therapeutics, Inc. $9.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
745 Vaccinex, Inc. $9.0 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
746 Aravive, Inc. $8.9 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
747 Soligenix, Inc. $8.4 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
748 Inhibikase Therapeutics, Inc. $8.3 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
749 Galera Therapeutics, Inc. $8.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
750 ASLAN Pharmaceuticals Limited $7.9 M

(Jan. 1, 2024)

 Singapore Singaporean Healthcare Singaporean Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2024

721. Acorda Therapeutics, Inc.

Company Profile: Acorda Therapeutics, Inc.
Market Cap (USD): $18.0 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

722. Cara Therapeutics, Inc.

Company Profile: Cara Therapeutics, Inc.
Market Cap (USD): $17.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

723. GlycoMimetics, Inc.

Company Profile: GlycoMimetics, Inc.
Market Cap (USD): $17.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

724. Lyra Therapeutics, Inc.

Company Profile: Lyra Therapeutics, Inc.
Market Cap (USD): $16.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

725. Acer Therapeutics Inc.

Company Profile: Acer Therapeutics Inc.
Market Cap (USD): $16.1 M (Nov. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

726. Akari Therapeutics, Plc

Company Profile: Akari Therapeutics, Plc
Market Cap (USD): $16.1 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

727. Onconova Therapeutics, Inc.

Company Profile: Onconova Therapeutics, Inc.
Market Cap (USD): $15.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

728. BioCardia, Inc.

Company Profile: BioCardia, Inc.
Market Cap (USD): $15.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

729. Aytu BioScience, Inc.

Company Profile: Aytu BioScience, Inc.
Market Cap (USD): $15.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

730. Frequency Therapeutics, Inc.

Company Profile: Frequency Therapeutics, Inc.
Market Cap (USD): $14.3 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

731. Aileron Therapeutics, Inc.

Company Profile: Aileron Therapeutics, Inc.
Market Cap (USD): $14.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

732. Celyad Oncology SA

Company Profile: Celyad Oncology SA
Market Cap (USD): $14.2 M (July 1, 2023)
Country: Belgium
Sector: Belgian Healthcare
Industry: Belgian Biotechnology

733. Edesa Biotech, Inc.

Company Profile: Edesa Biotech, Inc.
Market Cap (USD): $14.1 M (Jan. 1, 2024)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

734. Orgenesis Inc.

Company Profile: Orgenesis Inc.
Market Cap (USD): $13.9 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

735. Landos Biopharma, Inc.

Company Profile: Landos Biopharma, Inc.
Market Cap (USD): $13.7 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

736. PolyPid Ltd.

Company Profile: PolyPid Ltd.
Market Cap (USD): $12.8 M (Jan. 1, 2024)
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

737. Synairgen plc

Company Profile: Synairgen plc
Market Cap (USD): $12.7 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

738. Applied Molecular Transport Inc.

Company Profile: Applied Molecular Transport Inc.
Market Cap (USD): $11.0 M (Dec. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

739. ImmuPharma plc

Company Profile: ImmuPharma plc
Market Cap (USD): $10.9 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

740. ABVC BioPharma, Inc.

Company Profile: ABVC BioPharma, Inc.
Market Cap (USD): $10.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

741. Virios Therapeutics, LLC

Company Profile: Virios Therapeutics, LLC
Market Cap (USD): $10.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

742. Destiny Pharma plc

Company Profile: Destiny Pharma plc
Market Cap (USD): $10.3 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

743. Oncimmune Holdings plc

Company Profile: Oncimmune Holdings plc
Market Cap (USD): $10.2 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

744. Cyclerion Therapeutics, Inc.

Company Profile: Cyclerion Therapeutics, Inc.
Market Cap (USD): $9.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

745. Vaccinex, Inc.

Company Profile: Vaccinex, Inc.
Market Cap (USD): $9.0 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

746. Aravive, Inc.

Company Profile: Aravive, Inc.
Market Cap (USD): $8.9 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

747. Soligenix, Inc.

Company Profile: Soligenix, Inc.
Market Cap (USD): $8.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

748. Inhibikase Therapeutics, Inc.

Company Profile: Inhibikase Therapeutics, Inc.
Market Cap (USD): $8.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

749. Galera Therapeutics, Inc.

Company Profile: Galera Therapeutics, Inc.
Market Cap (USD): $8.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

750. ASLAN Pharmaceuticals Limited

Company Profile: ASLAN Pharmaceuticals Limited
Market Cap (USD): $7.9 M (Jan. 1, 2024)
Country: Singapore
Sector: Singaporean Healthcare
Industry: Singaporean Biotechnology

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch